CLINICOHEMATOLOGICAL, IMMUNOPHENOTYPING, MOLECULAR PROFILE, AND OVERALL SURVIVAL IMPACT IN ACUTE LYMPHOID LEUKEMIA PATIENTS FROM NORTH INDIA

Survival Impact in ALL

  • MANOJ KUMAR Department of Molecular Biology and Transplant Immunology, Indraprastha Apollo Hospitals, New Delhi, India.
  • MOHIT CHOWDHRY Department of Molecular Biology and Transplant Immunology, Indraprastha Apollo Hospitals, New Delhi, India.
  • RAJ NATH MAKROO Department of Molecular Biology and Transplant Immunology, Indraprastha Apollo Hospitals, New Delhi, India.
  • DEEPIKA RANI Department of Molecular Biology and Transplant Immunology, Indraprastha Apollo Hospitals, New Delhi, India.
  • VANDANA SHARMA Department of Molecular Biology and Transplant Immunology, Indraprastha Apollo Hospitals, New Delhi, India.
  • PANKAJ SHARMA Laboratory of Oxidative Stress and Cancer Biology, Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh,

Abstract

Objective: Cytogenetic plays an inevitable role in predicting the diagnosis of acute leukemia. The recurrent chromosomal aberrations in acute leukemia have provided critical insights into the pathophysiological mechanism of leukemogenesis. Cytogenetics findings at diagnostics provide important information for decision-making in both childhood and adult acute lymphoblastic leukemia (ALL). The cure rate for ALL is >80% in children and 35% in adults. Despite the therapeutic advances in ALL, several important biological and pathophysiological questions remain to be answered to achieve an accurate diagnosis, timely prognosis, and maximum therapeutic benefit.


Methods: The present study was carried out at tertiary care hospital, New Delhi, India. A total of 144 newly diagnosed ALL patients were analyzed for clinicohematological profile, immunophenotyping, conventional, and molecular cytogenetics.


Results: The study population was found to have normal karyotypes in most of the cases; however, abnormalities also reported. Our study clearly indicates that the application of fluorescence in situ hybridization has increased sensitivity and accuracy for detecting various chromosomal abnormalities, more so with the cryptic rearrangements.


Conclusion: We observed that the prevalence of the molecular subgroup of leukemia with a potential for a favorable clinical outcome (ETV6-RUNX1 and hyperdiploidy) in precursor B-ALL is higher in the North India.

Keywords: Cytogenetics, Chromosomal aberrations, Acute lymphoblastic leukemia

References

1. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-15.
2. Gaynon PS. Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 2005;131:579-87.
3. Pui CH, Sandlund JT, Pei D, Rivera GK, Howard SC, Ribeiro RC, et al. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 2003;290:2001-7.
4. Advani SH, Rao DN, Gopal R, Nair CN, Battacharya M. Acute lymphoblastic leukemia: End-result analysis of treatment and prognostic factors in Indian patients. Am J Hematol 1983;15:35-43.
5. Advani SH, Iyer RS, Pai SK, Gopal R, Saikia TK, Nair CN, et al. Four-agent induction/consolidation therapy for childhood acute lymphoblastic leukemia: An Indian experience. Am J Hematol 1992;39:242-8.
6. Advani S, Pai S, Venzon D, Adde M, Kurkure PK, Nair CN, et al. Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimen. Ann Oncol 1999;10:167-76.
7. Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber consortium protocol 91-01. Blood 2001;97:1211-8.
8. Wessels G, Hesseling PB, Buurman M, Oud C, Nel ED. An analysis of prognostic variables in acute lymphocytic leukaemia in a heterogenous South African population. J Trop Pediatr 1997;43:156-61.
9. Shanta V, Maitreyan V, Sagar TG, Gajalakshmi CK, Rajalekshmy KR. Prognostic variables and survival in pediatric acute lymphoblastic leukemias: Cancer institute experience. Pediatr Hematol Oncol 1996;13:205-16.
10. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030-43.
11. Mrózek K, Harper DP, Aplan PD. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2009;23:991-1010, v.
12. Chessels JM, Swansbury GJ, Reeves B, Bailey CC, Richards SM. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: Results of MRC UKALL X. Medical research council working party in childhood leukaemia. Br J Haematol 1997;99:93-100.
13. Harrison CJ, Moorman AV, Barber KE, Broadfield ZJ, Cheung KL, Harris RL, et al. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: A UK cancer cytogenetics group study. Br J Haematol 2005;129:520-30.
14. Waghray M, Rowley JD, Reddy PP, Reddy SV. A cytogenetic study of children in India with acute lymphocytic leukemia: Correlation with clinical data. Cancer Genet Cytogenet 1986;23:225-37.
15. Yang CP, Wu JH, Hung IJ, Jaing TH. Cytogenetic pattern of childhood leukemia in Taiwan. J Formos Med Assoc 2000;99:281-9.
16. Forestier E, Johansson B, Borgström G, Kerndrup G, Johansson J, Heim S, et al. Cytogenetic findings in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic countries. The NOPHO leukemia cytogenetic study group. Eur J Haematol 2000;64:194-200.
17. Pérez-Vera P, Mújica-Sánchez M, Carnevale A, Rivera-Luna R, Paredes R, Martínez A, et al. Cytogenetics in acute lymphoblastic leukemia in Mexican children: An institutional experience. Arch Med Res 2001;32:202-7.
18. Whitlock JA, Gaynon PS. Acute lymphoblastic leukemia in children. In: Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber D, et al, editors. Wintrobe’s Clinical Hematology. 12th ed., Vol. 2. Philadelphia, PA: Lippincott Williams and Wilkins; 2009. p. 1889-910.
19. Gladstone B, Amare PS, Pai SK, Gopal R, Joshi S, Nair CN, et al. Cytogenetic studies in patients from india with T-acute lymphoblastic leukemia. Cancer Genet Cytogenet 1998;106:44-8.
20. Amare P, Gladstone B, Varghese C, Pai S, Advani S. Clinical significance of cytogenetic findings at diagnosis and in remission in childhood and adult acute lymphoblastic leukemia: Experience from India. Cancer Genet Cytogenet 1999;110:44-53.
21. Li X, Li J, Hu Y, Xie W, Du W, Liu W, et al. A comprehensive cytogenetic classification of 1466 Chinese patients with de novo acute lymphoblastic leukemia. Leuk Res 2012;36:720-6.
22. Aricò M, Valsecchi MG, Rizzari C, Barisone E, Biondi A, Casale F, et al. Long-term results of the AIEOP-ALL-95 trial for childhood acute lymphoblastic leukemia: Insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. J Clin Oncol 2008;26:283-9.
23. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994;83:2780-6.
24. Onodera N, McCabe NR, Rubin CM. Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. Blood 1992;80:203-8.
25. Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2009;23:655-74.
26. Pui CH, Carroll AJ, Raimondi SC, Land VJ, Crist WM, Shuster JJ, et al. Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid less than 45 line. Blood 1990;75:1170-7.
27. Padhi S, Sarangi R, Mohanty P, Das R, Chakravarty S, Rand M, Jacob RT. Cytogenetic profile of pediatric acute lymphoblastic leukemia (ALL): Analysis of 31 cases with review of literature. Caryologia 2011;64:33 41.
28. Seeger K, von Stackelberg A, Taube T, Buchwald D, Körner G, Suttorp M, et al. Relapse of TEL-AML1 positive acute lymphoblastic leukemia in childhood: A matched-pair analysis. J Clin Oncol 2001;19:3188-93.
29. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995;9:1985-9.
30. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffé M, Jonveaux P, et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995;86:4263-9.
31. Settin A, Al Haggar M, Al Dosoky T, Al Baz R, Abdelrazik N, Fouda M, et al. Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia. Indian J Pediatr 2007;74:255-63.
32. Yehuda-Gafni O, Cividalli G, Abrahmov A, Weintrob M, Neriah SB, Cohen R, et al. Fluorescence in situ hybridization analysis of the cryptic t(12;21) (p13;q22) in childhood B-lineage acute lymphoblastic leukemia. Cancer Genet Cytogenet 2002;132:61-4.
33. Inamdar N, Kumar SA, Banavali SD, Advani S, Magrath I, Bhatia K, et al. Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India. Int J Oncol 1998;13:1319-22.
34. Jiménez-Morales S, Miranda-Peralta E, Saldaña-Alvarez Y, Perez-Vera P, Paredes-Aguilera R, Rivera-Luna R, et al. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: Prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients. Leuk Res 2008;32:1518-22.
35. Alonso CN, Gallego MS, Alfaro EM, Rossi JG. Caracterizacion molecular en leukemia linfoblastica aguda pediatrica en una institucion hospitalaria. Pediatric lymphoblastic leukemia molecular characterization in a single institution. Hematologica 2006;10:8-12.
36. Tiensiwakul P. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia. Cancer Genet Cytogenet 2004;149:85-8.
37. Tsang KS, Li CK, Chik KW, Shing MM, Tsoi WC, Ng MH, et al. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong. Am J Hematol 2001;68:91-8.
38. Liang DC, Chou TB, Chen JS, Shurtleff SA, Rubnitz JE, Downing JR, et al. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996;10:991-3.
39. Khan AA, Jameel T, Anwar M. Chromosomal changes in acute lymphoblastic leukemia. Pakistan J Pathol 1999;10:26-9.
40. Khalid S, Usman M, Adil SN, Ayub A, Khurshid M. Pattern of chromosomal abnormalities in adult acute lymphoblastic leukemia. Indian J Pathol Microbiol 2007;50:78-81.
41. Crist W, Carroll A, Shuster J, Jackson J, Head D, Borowitz M, et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A pediatric oncology group study. Blood 1990;76:489-94.
42. Chan LC, Kwong YL, Liu HW, Chan TK, Todd D, Ching LM, et al. Cytogenetic analysis of hematologic malignancies in Hong Kong. A study of 98 cases. Cancer Genet Cytogenet 1992;62:154-9.
43. Fletcher JA, Lynch EA, Kimball VM, Donnelly M, Tantravahi R, Sallan SE, et al. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991;77:435-9.
44. Russo C, Carroll A, Kohler S, Borowitz M, Amylon M, Homans A, et al. Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: A Pediatric oncology group study. Blood 1991;77:1050-6.
45. Oyekunle A, Haferlach T, Kröger N, Klyuchnikov E, Zander AR, Schnittger S, Bacher U. Molecular diagnostics, targeted therapy, and the indication for allogeneic stemcell transplantation in acute lymphoblastic leukemia. Adv Hematol 2011;2011:154745.
46. Olde Nordkamp L, Mellink C, van der Schoot E, van den Berg H. Karyotyping, FISH, and PCR in acute lymphoblastic leukemia: Competing or complementary diagnostics? J Pediatr Hematol Oncol 2009;31:930-5.
47. Safaei A, Shahryari J, Farzaneh MR, Tabibi N, Hosseini M. Cytogenetic findings of patients with acute lymphoblastic leukemia in Fars province. Iran J Med Sci 2013;38:301-7.
48. Pui CH, Chessells JM, Camitta B, Baruchel A, Biondi A, Boyett JM, et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003;17:700-6.
49. Schrappe M. Prognostic factors in childhood acute lymphoblastic leukemia. Indian J Pediatr 2003;70:817-24.
50. Trigg ME, Sather HN, Reaman GH, Tubergen DG, Steinherz PG, Gaynon PS, et al. Ten-year survival of children with acute lymphoblastic leukemia: A report from the children‘s oncology group. Leuk Lymphoma 2008;49:1142-54.
51. Horibe K, Hara J, Yagi K, Tawa A, Komada Y, Oda M, et al. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan association of childhood leukemia study. Int J Hematol 2000;72:61-8.
52. Shing MM, Li CK, Chik KW, Lam TK, Lai HD, Ng MH, et al. Outcomes and prognostic factors of Chinese children with acute lymphoblastic leukemia in Hong Kong: Preliminary results. Med Pediatr Oncol 1999;32:117-23.
53. Darji AA, Bharadia PD. Chronic myelogenous leukemia: A review and update of current and future therapy. Int J Pharm Pharm Sci 2016;8: 35- 46.
54. Gupta M, Dahiya J, Marwaha RK, Dureja H. Therapies in cancer treatment. An overview. Int J Pharm Pharm Sci 2015;7:1-9.
Statistics
93 Views | 16 Downloads
How to Cite
MANOJ KUMAR, MOHIT CHOWDHRY, RAJ NATH MAKROO, DEEPIKA RANI, VANDANA SHARMA, and PANKAJ SHARMA. “CLINICOHEMATOLOGICAL, IMMUNOPHENOTYPING, MOLECULAR PROFILE, AND OVERALL SURVIVAL IMPACT IN ACUTE LYMPHOID LEUKEMIA PATIENTS FROM NORTH INDIA”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 9, July 2019, pp. 164-71, https://innovareacademics.in/journals/index.php/ajpcr/article/view/34312.
Section
Original Article(s)